Nasobol Junior Schnupfen Xylo 0.05%
Nasobol Junior Schnupfen Xylo 0.05% is a medicine authorised by Swissmedic under authorisation number 65262. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 27 November 2015 and the authorisation is valid without a time limit. ATC code R01AA07 places the medicine in the group Nasal preparations.
| Authorisation number | 65262 |
|---|---|
| Name | Nasobol Junior Schnupfen Xylo 0.05% |
| Full name | Nasobol Junior Schnupfen Xylo 0.05%, Nasenspray |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R01AA07 |
| First authorisation | 27 November 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nasobol Junior Schnupfen Xylo 0.05%, Nasenspray | D | 27 November 2015 |
| 2 | Nasobol Schnupfen Xylo 0.1%, Nasenspray | D | 24 November 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 10 | ml | R01AA07 | 12.02.1. | D |
| 7 | 10 | ml | R01AA07 | 12.02.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nasobol Junior Schnupfen Xylo 0.05% authorised in Switzerland?
Yes. Nasobol Junior Schnupfen Xylo 0.05% is authorised by Swissmedic under authorisation number 65262, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nasobol Junior Schnupfen Xylo 0.05% have?
Nasobol Junior Schnupfen Xylo 0.05% is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Nasobol Junior Schnupfen Xylo 0.05%?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.